Author:
Zheng Yue,Wang Pei-pei,Fu Yang,Chen Yue-yun,Ding Zhen-Yu
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference43 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
2. Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers;Hopkins;Br. J. Cancer,2017
3. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann. Oncol.,2018
4. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial;Rosen;Cancer,2004
5. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial–the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group;Rosen;Journal of clinical oncology : official journal of the American Society of Clinical Oncology.,2003
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献